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AbShCt 
20s proteasomes are multifunctional proteinase complexes ubiquitous in eucaryotes. We have cloned the yeast PRE3 gene by complementation 
of the pre3-2 mutation, which leads to a defect in the peptidylglutamyl-peptide hydrolyzing activity of the 20s proteasome. The PRE3 gene, a p-type 
member of the proteasomal gene family, is essential for cellular life and codes for a 193-amino acid proteasomal subunit with a predicted molecular 
mass of 21.2 kDa. The Pre3 protein shows striking homology to the human proteasome subunits Hs.6 and Lmp2 (Ringl2). L.mp2 is encoded in the 
major histocompatibility complex class II region implicating proteasomes in antigen processing. 
Key words: Proteasome; Proteolysis (yeast); Antigen processing (human MHC) 
1. IIltruduction 
20s proteasomes are abundant proteinase complexes 
(molecular mass about 700 kDa) in the cytoplasm and 
nucleus of eucaryotic cells, highly conserved from yeast 
to man [1,2]. They are composed of a variable set of 
non-identical but structurally related subunits (molecu- 
lar masses ranging from 20 to 35 kDa) arranged in a 
hollow cylindrical structure. 20s proteasomes exhibit 
multiple, distinct catalytic activities including peptide 
bond cleavage on the carboxyl side of hydrophobic, 
basic and acidic amino acid residues. Three types of 
proteolytic activity have been referred to as chymotryp- 
sin-like, trypsin-like and peptidylglutamyl-peptide hy- 
drolyzing (PGPH) activities, respectively [3,4,5]. 
20s proteasomes act as the proteolytic core of a higher 
molecular mass complex (about 1,5 MDa), the 26s pro- 
teasome. In vitro studies demonstrated that modification 
by ubiquitin targets proteins for energy dependent degra- 
dation via the 26s complex [6,7]. 
In mammals, the presentation of intracellular proteins 
to the immune system requires their degradation to small 
peptides that then become associated with major histo- 
compatibility complex (MHC) class I molecules [8,9]. 
*Corresponding author. Fax: (49) (711) 685 4392. 
Abbreviations: Cbz, benzyloxycarbonyl; mA, B-naphthylamine; 
MHC, major histocompatibility complex; PGPH, peptidylglutamyl- 
peptide hydrolyzing. 
The antigenic peptides for MHC class I assembly may be 
provided by a ubiquitin-mediated proteolytic pathway 
[lo]. Two proteasomal subunits, the human proteins 
Ring 10 [ 1 I] and Ring1 2 [ 121 and their murine equivalents 
Lmp7 [13] and Lmp2 [14], respectively, are encoded 
within the MHC class II region, implicating special func- 
tions of proteasomes in antigen processing. In cells lack- 
ing these MHC-encoded proteasome subunits the effi- 
ciency of antigen processing should be reduced 
[15,16,17]. 
Yeast mutants prel-1 and pre2-2 deficient in the chy- 
motrypsin-like activity and pre4-I defective in the pepti- 
dyl glutamyl peptide hydrolyzing activity of the pro- 
teasome have given evidence that proteasomes are in- 
volved in the ubiquitin-mediated proteolytic pathway in 
vivo [l&-22]. Proteasomes were found to function in the 
degradation of the short-lived N-end rule protein sub- 
strates [19,20], metabolically regulated enzymes (Schork, 
S., Bee, G., Thumm, M. and Wolf, D.H., submitted) and 
abnormal proteins [23,24]. Proteasomes also have been 
shown to be involved in cell cycle control [25-271. Three 
yeast genes, PREl, PRE2, and PRE4, encoding pro- 
teasomal subunits necessary for proteolytic activities of 
the proteasome were cloned and sequenced. Each of 
them is essential for cell viability [l&21,22]. 
Here, we report on the cloning of the essential yeast 
PRE3 gene by complementation of the pre3-2 mutation, 
which leads to a defect in the peptidylglutamyl-peptide 
hydrolyzing (PGPH) activity of the proteasome. The 
PRE3 gene product shows striking homology to the 
human proteasome subunits HsJ [28] and Lmp2 
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(Ring12) [12] which is located in the MHC class II 
region. 
2. Materials and methods 
2.1. Yeast strains and manipulation 
Yeast S. cerevisiae strains were grown in complete (YPD) or minimal 
(SD) media prepared according to [29]. For genetic and molecular 
biological techniques tandard protocols were used [30-321. For trans- 
formation a protocol modified by Heinemeyer et al. [ 181 was followed. 
Yeast strains FABYSD-17C (MATa kex2 pral-I prbl-I prcl-I 
cpsl-3 prdl- his- lys- ade-) [21] and WCG4 (M>TaIMiTa his311 1,151 
his3-11.15 leu2-3.112/leu2-3.112 ura3/ura3 cans/cans) 1221 were used 
as proteinase yscE wild type. The mutant strain C13-9d (iViTa pre3-2 
prbl-1 prcl-1 ura3d5 his- lys-) is a derivative from thepre3-2 mutant 
strain Cl3 [33]. 
2.2. Isolation of mutants 
Mutants of the proteasomal PGPH activity were isolated after muta- 
genesis with ethylmethane sulfonate of strain FABYSD-17C using an 
in situ test with Cbz-Leu-Leu-GlumA as substrate [21,34]. The /I- 
naphthylamine released from the substrate by the PGPH activity was 
detected by coupling it to Fast Garnet GBC yielding a red azo dye. Pale 
mutant colonies were picked. Four mutant strains, C6 (pre3-I), Cl3 
(pre3-2), Cl9 @re3-3) and C35 (pre4-I), were isolated and biochemi- 
cally and genetically analyzed [21,34]. 
2.3. Gene cloning and analysis 
The PRE3 gene was cloned by complementation of the defective 
PGPH activity of the pre3-2 mutant strain C13-9C using a yeast 
genomic library in the CEN4-ARSI-URA3 shuttle vector YCp50 [35]. 
One recombinant YCp50 plasmid restored the PGPH activity in the 
pre3-2 mutant strain. Restriction mapping revealed a 6.9 kbp genomic 
DNA insert. The complementing DNA sequence was limited to 3.2 kbp 
after cloning of subfragments into the vector YCp50 (Fig. 1). For 
sequence analysis the complementing DNA was cloned as an EcoRV 
fragment in both directions into the EcoRV-cut vector pBluescript SK 
(Stratagene). Stepwise deletions nesting the insert of each pBluescript 
SK-based plasmid were generated by the Exonuclease IIBExonuclease 
VII digestion method [36]. The plasmid was cut at the unique polylinker 
sites BamHI and Sac1 and then digested with Exonuclease IIIIExonu- 
clease VII (Boehringer Mannheim, Germany), yielding a series of 
pBluescript SK-based plasmids with DNA segments overlapping the 
PRE3 region. These plasmids served as template DNA. Nucleotide 
sequencing of both DNA strands was performed using the T7-Polym- 
erase DNA-Sequencing Kit from Pharmacia (Freiburg, Germany) and 
the reversed primer which binds adjacent o the polylinker. 
2.4. Chromosomal deletion of PRE3 
A 2.3 kbp EcoRI-SalI fragment harboring the PRE3 gene was cloned 
in the vector pSP64 yielding pJK2. Plasmid pJK2 was-digested at the 
nolvlinker sites Hind111 and SalI, the ends were filled un using the 
-K&row reaction and religated to yield pJK3. Plasmid pJK3 was l&ear- 
ized using the PstI site located in the PRE3 gene and digested with 
exonuclease Ba131 until 248 bp were removed between the ends. The 
ends were religated using a BamHI linker yielding pJK6. The PRE3 
NW1 
Kpnl Kpnl 
ECORI PItI PVUII 
deletion (Figs. 1 and 2, nucleotides from position 131 to 379) was 
verified by sequencing. A 1.8 kbp BamHI fragment containing the HZS3 
gene was inserted into the BamHI-cut pJK6 yielding the PRE3 deletion 
allele (Fig. 1). The pre3d::HIS3 deletion allele was-transformed as a 3 
kbp EcoRI-MluI fragment into the histidine-auxotroohic dioloid wild 
type strain WCG4. II&+ transformants were selected. -The replacement 
of one of two copies of PRE3 with the dabeletion allele was confirmed 
by Southern blot analysis (one step gene disruption; see [32]). The 
PRE3/pre3d::HIS3 heterozygous diploids were sporulated, and asci 
were subjected to tetrad analysis. Of each tetrad, viability of only two 
His- spores was observed. 
3. Results and discussion 
We had isolated four mutants (C6, C13, Cl9 and C35) 
deficient in the pcptidylglutamyl-peptide hydrolyzing 
(PGPH) activity of proteinase yscE, the yeast pro- 
teasome, via their defect in the activity against the pep- 
tide substrate Cbz-Leu-Leu-Glu-/3NA [34]. The genetic 
analysis of these mutants revealed two complementation 
groups, PIPE3 and PRE4. The mutant alleles were called 
pre3-2 (C6), pre3-2 (13), pre3-3 (C19) and pre4-1 (C35) 
[21]. The mutants Cl3 (pre3-2) and C35 (pre4-1) were 
completely devoid of proteolytic activity against Cbz- 
Leu-Leu-Glu$NA. The mutant strains C6 and Cl9 ex- 
hibited residual activities against Cbz-Leu-Leu-Glu- 
j?NA of 17% and 30% as compared to wild type. 
The PRE3 gene was cloned from a yeast genomic li- 
brary [35] by complementation of the peptidylglutamyl- 
peptide hydrolyzing (PGPH) activity of the pre3-2 mu- 
tant strain C13-9C. 
Sequence analysis of the complementing DNA region 
(Fig. 1) revealed an open reading frame that encodes a 
193-amino acid protein with a predicted molecular mass 
of 21.2 kDa (Fig. 2). 
Data bank search revealed, that the PRE3 gene is 
located 370 bp downstream of the CENlO nucleotide 
sequence [37] as shown in Fig. 1. Therefore, PRE3 is 
mapped to the right arm of chromosome X. 
The chromosomal deletion of the PRE3 gene is lethal. 
Sporulation of heterozygous diploids (PRE3lpre3A:: 
HIS3) yielded two wild type spores which grew up to 
colonies and two null mutant spores which germinated, 
but were unable to proliferate. Thus the PRE3 gene 
product like the hitherto cloned proteasomal subunits 
SnaBl Mlul Sal1 
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Fig. 1. Restriction map of the PRE3 locus and deletion. The 1.4 kbp NncI-SnaBI fragment represents the shortest DNA streach complementing the 
pre3-2 mutation. Dashed lines indicate the region of PRE3, that was replaced with HZS3 (see section 2). 
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Fig. 2. Nucleotide sequence of the PRE3 gene and deduced amino acid 
sequence of the Pre3 Protein. 
necessary for proteolytic activities of the proteasome 
[18,21,22] was proven to be essential for cellular life. 
Molecular analysis of the Pre3 protein and proteins of 
yeast and higher eucaryotes identified as components of 
proteasomes demonstrate that the PRE3 gene product is 
a subunit of the yeast proteasome. The Pre3 protein can 
be classified as a member of the p-type proteasome gene 
family [38]. Thus the up to now identified subunits which 
can be linked to proteolytic activity of the complex are 
all of the /?-type [18,21,22]. This gives evidence for the 
idea that the p-subunits of the 20s proteasome may exert 
catalytic functions whereas the a-subunits may be 
needed for the assembly and regulation of the 20s and/or 
26s proteasome complex. Using the EMBL PROSITE 
database a sequence motif WDGSS which is typical for 
glutamine synthetases [39] was found within the Pre3 
sequence located at the highly conserved j3II region (Fig. 
3). As glutamine synthetase also the Pre3 subunit may 
recognize or bind glutamyl residues as a part of the 
proteasomal PGPH-substrate. Besides the conserved do- 
mains characteristic for B-type proteasomal subunits no 
striking homology between the Pre3 protein and the gene 
products of PREl, PRE2 and PRE4 was found (not 
shown). 
The alignment of the Pre3 protein with the H.&i sub- 
unit of the human proteasome (55% identity, 77% simi- 
larity) and the human MHC-encoded protein Lmp2 
(Ring12) (44% identity, 69% similarity) is shown in Fig. 
3. In human cells deletion of LMP2 does not lead to 
lethality, whereas the PRE3 gene is essential for the yeast 
cell. This result suggests that as Pre3 in yeast the most 
homologous subunit HSS in human cells may perform 
house-keeping functions whereas the Lmp2 subunit may 
be needed for specific tasks, as is antigen processing. 
Recently it has been reported that deletion as well as 
y-interferon induced expression of the MHCII-encoded 
Lmp2 and Lmp7 proteins changes the proteolytic activi- 
ties of the respective proteasomes [l&16]. Pre3 as the 
1 ____________ M N Q T 1 E-T V G I T L K D ta-beta 
1 ________________-______ 
1 
+'""'" D, rc-PRE3 
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Fig. 3. Alignment of the/?-subunit from archaebacteriae Z acidophilum 
[38], the yeast Pre3 protein, the Hs6 subunit of the human proteasome 
[28], and the human MHC-encoded Lmp2 (Ring12) protein [12]. Gaps 
are inserted for optimal alignment. Identical amino acids are indicated 
by boxes. The glutamine synthetase motif is shown by the filled box. 
The consensus PROS box domains defining members of the B-type 
proteasome family are underlined. 
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yeast homologue of Lmp2 is necessary for the PGPH- 
activity of the proteasome. This finding supports the idea 
that Lmp2 is needed for the catalytic function of the 
proteasome and modulates the proteolytic acivity to im- 
prove antigen processing. 
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